Kodiak Sciences Inc.
For the period ended Dec 31, 2025. Filed Mar 31, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 31, 2026
KOD$107.10+7.9%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Financial Statements and Supplementary Data
INDEX TO CONSOLIDATED FINANCIAL STATEMENTS
| Page | |||
|---|---|---|---|
| Report of Independent Registered Public Accounting Firm (PCAOB ID: 238) | 78 | ||
| Consolidated Balance Sheets | 80 | ||
| Consolidated Statements of Operations and Comprehensive Loss | 81 | ||
| Consolidated Statements of Stockholders’ Equity | 82 | ||
| Consolidated Statements of Cash Flows | 83 | ||
| Notes to Consolidated Financial Statements | |||
| Note 1. | The Company | 84 | |
| Note 2. | Summary of Significant Accounting Policies | 84 | |
| Note 3. | Property and Equipment, Net | 89 | |
| Note 4. | Accrued and Other Current Liabilities | 89 | |
| Note 5. | Fair Value Measurements | 89 | |
| Note 6. | Marketable Securities | 90 | |
| Note 7. | Derivatives | 90 | |
| Note 8. | Commitments and Contingencies | 90 | |
| Note 9. | Income Taxes | 92 | |
| Note 10. | Common Stock | 95 | |
| Note 11. | Stock-Based Compensation | 95 | |
| Note 12. | Segment Information | 97 | |
| Note 13. | Net Loss Per Common Share | 98 | |
| Note 14. | 401(k) Plan | 98 | |
| Note 15. | Liability Related to Sale of Future Royalties | 99 | |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.